Biological Aspects of Conformal Therapy

References

• Agren A, Brahme A, Turesson I. Optimization of uncompli-cated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990; 19: 1077–85.
   PubMed Web of Science ®Google Scholar
• Brahme A. Optimisation of radiation therapy for cancer patients. Forum 1994; 4: 569–84.
   Google Scholar
• Kallman P, Agren A, Brahme A. Tumor and normal tissue response to fractionated non-uniform dose delivery. Int J Radiat Biol 1992; 62: 249–62.
   Google Scholar
• Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 1997; 4: 103–10.
   Google Scholar
• Niemierko A, Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol 1993; 29: 140–7.
   PubMed Web of Science ®Google Scholar
• Niemierko A, Goitein M. Dose-volume distributions (DVD's): a new approach to dose-volume histograms in three-dimensional treatment planning. Med Phys 1994; 21: 3–11.
   PubMedGoogle Scholar
• Soderstrom S, Brahme A. Optimization of the dose delivery in a few field techniques using radiobiological objective func-tions. Med Phys 1993; 20: 1201–10.
   PubMedGoogle Scholar
• Terahara A, Niemierko A, Goitein M, et al. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys 1999; 45: 351–8.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491–500.
   PubMed Web of Science ®Google Scholar
• Ang KK, Thames HD, Peters U. Altered fractionation sched-ules. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 3rd ed. Philadelphia: Lippincott, 1997: 119–42.
   Google Scholar
• Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981–2.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother Oncol 1994; 32: 1–11.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard J, Thames HD, et al. Clinical radio-biology of malignant melanoma. Radiother Oncol 1989; 16: 169–82.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Hall EJ. Fractionation and protraction for radio-therapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999; 43: 1095–101.
   PubMed Web of Science ®Google Scholar
• Chappell R, Nondahl DM, Rezvani M, Fowler JF. Further analysis of radiobiological parameters from the first and second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33: 509–18.
   PubMed Web of Science ®Google Scholar
• Duchesne GM, Peters U. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy (editorial). Int J Radiat Oncol Biol Phys 1999; 44: 747–8.
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Preuss-Bayer G, Trott KR. The influence of the number of fractions and overall treatment time on local control and late complication rate in squamous cell carcinoma of larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321–8.
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Withers HR, Taylor JMG, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part I. Tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 1989; 16: 831–43.
   PubMed Web of Science ®Google Scholar
• Stuschke M, Thames HD. Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysisof the randomized hyperfractionation trials. Radiother Oncol 1999; 51: 113–21.
   PubMed Web of Science ®Google Scholar
• Thames HD Jr, Hendry JH. Fractionation in radiotherapy. London: Taylor & Francis, 1987.
   Google Scholar
• Thames HD Jr, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relation-ships. Int .1- Radiat Oncol Biol Phys 1982; 8: 219–26.
   PubMedGoogle Scholar
• Withers HR, McBride WH. Biologic basis of radiation ther-apy. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. 3rd ed. New York: JP Lippincott-Raven, 1997: 79–118.
   Google Scholar
• Withers HR, Peters LJ, Taylor JMG, et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int .1- Radiat Oncol Biol Phys 1995; 33: 549–62.
   PubMed Web of Science ®Google Scholar
• Withers HR, Peters LJ, Taylor JMG, et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int .1- Radiat Oncol Biol Phys 1995; 33: 563–8.
   PubMed Web of Science ®Google Scholar
• Withers HR, Thames HD Jr, Peters U. A new isoeffect curve for change in dose per fraction. Radiother Oncol 1983; 1: 187–91.
   PubMedGoogle Scholar
• Wong CS, Minkin S, Hill RP. Linear-quadratic model under-estimates sparing effect of small doses per fraction in rat spinal cord. Radiother Oncol 1992; 23: 137–210.
   Google Scholar
• Haustermans KM, Hofland I, Van Poppel H, et al. Cell kinetic measurements in prostate cancer. Int .1- Radiat Oncol Biol Phys 1997; 37: 1067–70.
   PubMed Web of Science ®Google Scholar
• Goitein M, Niemierko A, Okunieff P. The probability of controlling an inhomogeneously irradiated tumor: a stratagem for improving tumor control through partial tumor boosting. In: Faulkner K, Corey B, Crellin A, Harrison RM, eds. Proc. 19th LH Gray Conference. London: British Insti-tute of Radiology, 1997: 25–39.
   Google Scholar
• Barton MB, Keane TJ, Gadalla T, Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137–45.
   PubMed Web of Science ®Google Scholar
• Hendry JH, Roberts SA, Slevin NJ, Keane TJ, Barton MB, Agren-Cronqvist A. Influence of radiotherapy treatment time on control of laryngeal cancer: comparisons between centres in Manchester, UK and Toronto, Canada. Radiother Oncol 1994; 31: 14–22.
   Google Scholar
• Keane TJ, Fyles A, O'Sullivan B, Barton M, Maki E, Simm J. The effect of treatment duration on local control of squamous carcinoma of the tonsil and carcinoma of the cervix. Sem Rad Oncol 1992; 2: 26–8.
   Google Scholar
• Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993; 25: 391–7.
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Majewski S. Dose fractionation and tumour repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991; 21: 163–70.
   PubMed Web of Science ®Google Scholar
• Petereit DG, Sarkaria JN, Chappell R, et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1301–7.
   PubMed Web of Science ®Google Scholar
• Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer-the time factor. Int J Radiat Oncol Biol Phys 1997; 39: 831–6.
   PubMedGoogle Scholar
• Robertson C, Robertson AG, Hendry JH, et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of car-cinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998; 40: 319–29.
   PubMed Web of Science ®Google Scholar
• Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiother-apy. Acta Oncol 1988; 27: 131–46.
   Google Scholar
• Steel GG. Growth kinetics of tumors. New York: Oxford University Press, 1977.
   Google Scholar
• Suwinski R, Taylor JMG, Withers HR. Rapid growth of microscopic rectal cancer as a determinant of response to preoperative adjuvant therapy. Int J Radiat Oncol Biol Phys 1998; 42: 943–51.
   Google Scholar
• Suwinski R, Lee SP, Withers HR. Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 1998; 40: 797–806.
   PubMed Web of Science ®Google Scholar
• Ang KK. Impact of overall time factor of radiation or combined therapy on the treatment outcome of advanced head and neck cancer. In: Paliwal B, Fowler JF, Herbert DE, Mehta MP, eds. Volume kinetics in tumor control and normal tissue complications. Madison: Med Phys Publishing, 1998: 289–306.
   Google Scholar
• Laird AK. Dynamics of tumor growth: Comparison of growth rates and extrapolation to one cell. Br J Cancer 1965; 18: 278–91.
   Google Scholar
• Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995; 32: 1227–37.
   PubMed Web of Science ®Google Scholar
• Shipley WU, Verhey LJ, Munzenrider JE, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995; 32: 3–12.
   PubMed Web of Science ®Google Scholar
• Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: volume effects. Med Phys 1983; 10: 410–5.
   Google Scholar
• Withers HR, Taylor JMG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988; 14: 751–9.
   PubMed Web of Science ®Google Scholar
• Maguire PD, Sibley GS, Zhou SM, et al. Clinical and dosi-metric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 1999; 45: 97–103.
   PubMed Web of Science ®Google Scholar
• Marks LB. The impact of organ structure on radiation re-sponse. Int J Radiat Oncol Biol Phys 1996; 34: 1165–71.
   PubMedGoogle Scholar